Psychedelics as Medicine: Do LSD and MDMA Really Work?

Psychedelic substances such as LSD, MDMA, and psilocybin are emerging as promising therapeutic options for treating mental health disorders. Hundreds of compounds are undergoing clinical trials, and investor money is flowing into the sector worldwide. But what are the risks?

LSD, MDMA, and psilocybin were once associated primarily with the hippie movement and the drug epidemic. Today, the picture has changed dramatically: psychedelic substances have become the focus of scientific research and are increasingly being considered as potential medicines against mental health disorders.

What conditions are being treated?

Clinical trials are focused primarily on treating depression, post-traumatic stress disorder (PTSD), anxiety disorders, and addictions. For example, psilocybin, found in certain mushroom species, has been tested in the treatment of severe depression, and early results have been promising. MDMA-based therapy has been studied in PTSD patients, although the US Food and Drug Administration (FDA) initially rejected approval of the first such drug in 2024, requesting additional data.

Investors and regulators are taking steps

Investor money is flowing into the psychedelic medicine sector worldwide: many biotechnology companies are currently conducting clinical trials of various psychedelic compounds. Regulators have also become more receptive, with several countries establishing special procedures that allow previously prohibited substances to be approved more quickly for therapeutic use. Even US President Donald Trump has supported expedited approval processes for certain psychedelic medicines.

What are the risks?

Despite promising results, psychedelic therapy carries significant risks. Study participants may experience intense psychological reactions, including anxiety and paranoia. A critical question is also the investigation of long-term effects; many studies have been short-term and small in sample size. Additionally, the therapeutic use of psychedelics raises questions about patient consent, the role of the therapist, and potential misuse.

Scientists emphasise that psychedelic therapy does not simply mean taking a pill; it takes place in strictly controlled conditions with professional psychological support. The field is still young, and much more scientific evidence is needed before widespread clinical adoption.